ADA快速血糖检测深层次问题.pdfVIP

R e v i e w s / C o m m e n t a r i e s / A D A S t a t e m e n t s R E V I E W Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management KATHLEEN DUNGAN, MD1 SUSAN S. BRAITHWAITE, MD3 source of the sample, and specimen ma- J OHN CHAPMAN , PHD2 J OHN BUSE, MD, PHD3 trix (i.e., plasma versus whole blood). This study will review assay principles, patient variables, and systematic variables an den Berghe et al. (1) reported a 180 mg/dl” for critically ill patients (4). and then encourage clinicians to carefully significant reduction in mortality The American Association of Clinical consider how standard recommendations Vwith normoglycemia (target value Endocrinologists recommends the “upper regarding glycemic targets, particularly in 80–110 mg/dl) in patients whose medical limits for glycemic targets” of 110 mg/dl the ICU, should be implemented in their intensive care unit (ICU) stay was 72 h in critically ill patients (5). individual health care facilities. and reduced morbidity in all patients, re- In practice, it may be difficult to ob- gardless of the duration of ICU stay. Al- tain the level of glycemic control (average though severe hypoglycemia did not glucose 111 mg/dl in the intensively man- ASSAY PRINCIPLES — In this re- occur in the Van den Berghe et al. study, aged group) achieved by Van den Berghe view, we will signify refe